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microRNAs are pervasive small noncoding ~22 nt gene regulators that 
collectively control the expressions by destabilizing mRNA or repressing translation. 
Several thousand of miRNA genes have been reported in mammalians that mostly are 
generated through canonical pathway while non-canonical miRNAs are not always 
generated in the same pathways. Mirtrons are one of miRNA variations that bypass 
Drosha cleavage step and instead are produced by splicing mechanism. There are 3 
classes of mirtrons: conventional, 5’- and 3’-tailed. In tailed mirtrons, splicing defines 
both pre-miRNA hairpin ends. Plenty of studies have been done on mirtrons but still 5’-
tailed mirtrons processing has remained unclear. Here, we studied the biogenesis of 
human 5’-tailed mirtrons and the role of Ribonucleases in processing the tails. To address 
this, we engineered miR-5010 tail on the 5p end and examined their biogenesis changes. 
Our analysis on RNA sequencing revealed that in miR-5010, RNase P complex is 
involved in processing the 5p tails by its endoribonuclease activity. We also 
demonstrated that when Rpp30 (subunit of RNase P) is downregulated, the mirtrons 
undergo “Arm Switching”. Besides, XRN family exoribonucleases seem to degrade the 
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1 
CHAPTER I - INTRODUCTION 
1.1 Non-Coding RNAs 
Messenger RNAs (mRNAs) are the middlemen of information flow in cells being 
intermediates between DNA and proteins. However, many RNA molecules are non-
coding RNAs (ncRNA) functioning by regulating mRNAs (Delihas, 2015; 
Diamantopoulos, Tsiakanikas, & Scorilas, 2018). As the name implies, ncRNAs are 
RNAs that do not code for protein, splitting them from mRNA, their coding counterparts. 
The first ncRNAs were identified in the late 1950s with the discovery of transfer RNAs 
(tRNAs) and ribosomal RNAs (rRNAs), and since then other classes have surfaced 
(Palazzo & Lee, 2015; P. Zhang, Wu, Chen, & Chen, 2019), such as microRNAs 
(miRNAs), small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs) and others 
(Mattick & Makunin, 2006; Shahrouki & Larsson, 2012). This ncRNA family is much 
larger compared to coding RNAs. Alteration in the expression of ncRNAs, may 
contribute to pathological phenotypes including cancers and diseases such as 
Alzheimer’s, Autism, and heart diseases and this makes them a very broad and 
significantly important area of study (Knoll, Lodish, & Sun, 2015; Wang, Han, Sun, 
Chen, & Chen, 2019; L. Zhou et al., 2018). These findings suggest that ncRNAs are 
associated with the complexity of prokaryote and higher eukaryotes involved in a 
plethora of diverse functions (Geisler & Coller, 2013). Different ncRNAs have role in 
different cellular processes where mostly are involved in translation and regulations. In 
addition, they function in RNA splicing and DNA replication (Cheng et al., 2005; 
Mattick & Makunin, 2006). ncRNAs are divided into two main categories according to 
their transcript sizes: long non-coding RNAs (lncRNAs) which are longer than 200 nt and 
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small non-coding RNAs (sncRNAs) with a length typically lower than 100 nt. The small 
ncRNAs are generated through a variety of pathways (Menezes, Balzeau, & Hagan, 
2018; K. Miyoshi, T. Miyoshi, & H. Siomi, 2010; Okamura, Hagen, Duan, Tyler, & Lai, 
2007; Ragusa et al., 2017).  
 
1.2 MicroRNAs 
miRNAs are small non-coding ~22 nucleotides RNAs which are mostly 
transcribed by RNA polymerase II and processed into precursor miRNA (pre-miRNAs) 
by folding into a stem- loop structure. The ubiquitous presence of different miRNAs 
along with their target sites in many living organisms suggests an evolutionary ancient 
origin and strong conservation (Ladewig, Okamura, Flynt, Westholm, & Lai, 2012; 
Xiong, Schneider, Hulsey, Meyer, & Franchini, 2019). Thousands of miRNAs have been 
discovered in plants, animals, fungi and viruses indicating an ancient origin of evolution. 
Many families of miRNAs as well as their target sites are conserved among species 
which demonstrates similar evolutionary pathways (Xiong et al., 2019). These small 
RNAs bind to effector proteins, Argonautes (Ago), to form RNA-Induced Silencing 
Complex (RISC) complexes. The miRNA guides the complex to the targets typically 
found in the 3’ UTR of the mRNAs and form Watson-Crick base pairing (Ma et al., 2005; 
O'Brien, Hayder, Zayed, & Peng, 2018; Parker, 2010; Parker, Roe, & Barford, 2005). 
Then miRNAs trigger deadenylating and decapping of the target mRNA with 
collaboration of Ago and several other proteins. Therefore, the poly(A) tail of the mRNA 
and the 5’ cap cannot synergize which results in the translational inhibition of the 
mRNAs (Okamura et al., 2007). A single microRNA can regulate the expression of 
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several mRNAs and a single mRNA may be regulated by more than one miRNA (Bartel, 
2018; Flynt, Greimann, Chung, Lima, & Lai, 2010; Ragusa et al., 2017). miRNAs play 
critical roles in cellular development and processes and as such they are linked to a 
number of complex diseases from cancers to fertility and growth complications. For 
example, miR-196a, miR-124a and miR-132 have been reported to be associated with 
esophageal squamous cell carcinomas, neurodegenerative disease and Huntington’s 
disease, respectively (Bloomston et al., 2007; C. Chen, Zhang, Zhang, Weakley, & Yao, 
2011; Fendereski et al., 2017; Tam, de Borja, Tsao, & McPherson, 2014). Additionally, 
miR- 34/449 are implicated with male and female infertility as well as growth retardation. 
Therefore, it is inferred that miRNAs greatly influence the expression patterns of many 
genes with different functionalities (Ardekani & Naeini, 2010; K. Miyoshi et al., 2010; 
Xu et al., 2013).  
 
1.2.1 miRNAs: A Historical Perspective 
miRNAs were first noted in early 1990s when a 22 nucleotide RNA transcript of 
the lin-4 gene in nematode Caenorhabditis elegans was discovered to be controlling 
another gene’s expression, lin-14. Without coding for any protein, lin-4 was decreasing 
the level of lin-14 expression. After that, Lee et al. discovered that there is a sequence on 
lin-4 which is complementary to the 3’ Untranslated Region of the lin-14 mRNA. Then, 
they postulated that an endogenous small RNA transcript is decreasing gene expressions 
(R. C. Lee, Feinbaum, & Ambros, 1993). Therefore, lin-4 was named the first miRNA 
capable of regulating the gene expression via partial base pair complementary with 
mRNAs. However, this was dismissed due to lack of homologs in other organisms 
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concluding that probably this has been an isolated example in worms resulting in gene 
knockdown. However, several years after that when the same mechanisms were detected 
extensively distributed in eukaryotes, these small RNAs were categorized as a class of 
regulatory molecules (Lau, Lim, Weinstein, & Bartel, 2001; R. C. Lee & Ambros, 2001; 
Wightman, Ha, & Ruvkun, 1993). Another miRNA (21 nt) was then discovered in 2000 
in C. elegans. This small RNA was named let-7 and since it is highly conserved across 
species, impacted the study of this specific miRNA (Kaufman & Miska, 2010). Let-7 was 
also detected in human and is associated in the late larval stages in adult transition 
(Reinhart et al., 2000) (Pasquinelli et al., 2000). Since then, several other short RNAs 
were discovered and interests in this field have soared paralleled with increasing number 
of miRNAs annotations across all species.  
 
1.3 tRNAs 
Transport RNAs (tRNA) are another class of noncoding RNAs that are involved 
in the translation of mRNA coding sequence into proteins. There are more than 500 
tRNA genes in the human genome and they are initially transcribed by RNA Polymerase 
III in the nucleus to produce pri-tRNAs that undergo maturation process before they form 
“Cloverleaf” conformation.  At this point, they bear 5p and 3p tails as “Leader” and 
“Trailer” sequences, respectively (Woese, Olsen, Ibba, & Soll, 2000). To become mature, 
tRNAs encounter processing events including 5p leader processing performed by RNase 
P complex and 3p trailer trimming performed by RNase Z family. A non-templated 
“CCA” motif is added to their 3’ end of the resulting pre-tRNA from previous step by 
CCA-adding enzyme. The yielded end-matured tRNAs are detected by “Exportin-t” to be 
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exported to the cytoplasm. It is vital for cell to generate sufficient mature tRNAs to 
support the protein synthesis efficiently especially in fast growing cells (Ohira & Suzuki, 
2011, 2016).  
 
1.4 Mechanisms of microRNA Biogenesis 
The biogenesis of most miRNA starts with Drosha a ribonuclease III which has 
endoribonucleolytic activity and participates in RNA maturation in the cell nucleus. 
miRNAs biogenesis is initiated by the transcription of pri-miRNAs (Fortin, Nicholson, & 
Nicholson, 2002; O'Brien et al., 2018). Drosha is in association with a protein called 
DGCR8 which is essential for the activity of Drosha. A “UGU” motif sequence in ~60% 
of hairpin loops guides DGCR8 to find hairpin loop. Then, Drosha recruits “UG” and 
“CNNC” motifs sequences on 5’ and 3’ flanking regions to situate on the hairpin and cut 
nearly one helical turn into the stem 16-18 nt upstream of “CNNC” motif. The released 
pre-miRNA is 55-80 nt long and leaves a 2-nucleotide overhang at the 3’ end, which 
makes it available for Exportin-5 (XPO5) identification (Denli, Tops, Plasterk, Ketting, 
& Hannon, 2004; Han et al., 2006; X. Zhang & Zeng, 2010). XPO5 is thought to be the 
major gate for transporting the pre-miRNAs to the cytoplasm. It has been reported that 
many miRNAs can be processed without XPO5. However, miR-320 requires XPO1 
instead of XPO5 (Westholm & Lai, 2011). After exported to the cytoplasm, pre-miRNA 
is further cut by Dicer, another ribonuclease III in associated with a partner protein 
TRBP. Both strands are cut close to the hairpin loop and a miRNA duplex is generated 
which contains the guide strand paired to the passenger strand with ~2 nt 3’ overhang on 
each end. Subsequently, the miRNA duplex is loaded into the AGO to form the core of 
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the RISC complex (R. Li, Jia, Zou, & Zhao, 2014; K. Miyoshi et al., 2010; Ragusa et al., 
2017). There are 8 members of the AGO family in humans. AGO1-4 have the ability to 
load miRNAs but only AGO2 has endonuclease activity. It has indicated that mice with 
catalytically inactive AGO2 die shortly after birth (K. Miyoshi et al., 2010). Compared to 
other Argonaute members, AGO2 is different in N-terminus and the PAZ-PIWI domain 
linkage space (Meister et al., 2004). The process starts by loading small RNA from the 
Dicer activity into the AGO2. Then the PAZ domain recognizes the 3’ end of miRNAs 
(Tang, 2005). The 5’ phosphate of miRNA is placed between PIWI and the Mid domains 
of the AGO protein. The enzymatic activity of the PIWI domain cuts the passenger 
 
 
Figure 1.1: Canonical miRNAs Biogenesis Pathway. Canonical miRNAs 




strand. Argonaute then takes the miRNA to the target mRNA and induces mRNA 
degradation or translational repression usually by binding to the 3’ UTR region. The 
miRNA strands are selected as passengers or guides depending on the thermodynamic 
stability of each end of the duplex. The strand with more stability on its 5’ terminal 
nucleotides is selected as the passenger strand and is degraded, while the other strand 
becomes mature miRNA (Figure 1) (Hutvagner & Simard, 2008; Y. K. Kim, Kim, & 
Kim, 2016).  
 
1.5 Non-Coding miRNAs 
In 2007, 14 short introns were identified as an alternative pathway for miRNA 
biogenesis. Small RNA clusters that originated from the outer edges of 56-nt introns. 
These sets of reads were very similar to the sets observed for the miRNA:miRNA* 
duplex. The sets were complementary to each other and that their 5’ ends were more than 
3’ ends. In addition, the majority of the sets contained 2-nt 3’ overhangs which mimicked 
them as Drosha products. Moreover, the predicted structure and the sequence were 
conserved in a pattern similar to that of pre-miRNAs. Despite the similarities with 
canonical miRNAs, pairing was stopped at the hairpin base and did not go over 
miRNA:miRNA* duplex which is necessary for Drosha to cleave the pri-miRNA. In the 
site that the pairing was extended, the reads showed conserved splice sites. This led them 
to the idea that these miRNAs did not originate from the canonical miRNA biogenesis 
pathway. Instead, an alternative pathway in which splicing defines pre-miRNA 
processing rather than Drosha cleavage is in place (Figure 2.1). As in the structure 
predictions, the terminal nucleotides characterize the first or last nucleotides of intronic 
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regions. They named their introns “Mirtron”s (Okamura et al., 2007; Ruby, Jan, & Bartel, 
2007; Sibley et al., 2012). Moreover, tRNAs, rRNAs and some snoRNAs provide another 
sources of non-canonical pre-miRNAs that are independent of microprocessor-mediated 
processing. The initial excised structure when spliced forms a “Lariat” which is 
linearized by Ldbr (Lariat Debranching) enzyme (Han et al., 2004; K. Miyoshi et al., 
2010; Seow, Sibley, & Wood, 2012; Zia & Flynt, 2018). Subsequently, the Ldbr 
ribonucleolytic activity processes the 3’-lariat tail, linearizes the intron and forms pre- 
miRNA hairpins that are suitable targets for Dicer cleavage. The spliceosome is then 
disassembled and recycled (Arenas & Abelson, 1997). Mirtrons then enter the canonical 
miRNA biogenesis pathway and then are exported to the cytoplasm by XPO-5. However, 
some studies have shown that mirtrons are not XPO-5 dependent and they utilizing other 
mechanisms for exporting to cytoplasm besides XPO-5 (Seow et al., 2012). Three types 
of mirtrons are conventional, 5’-tailed and 3’-tailed and splicing defines both ends of the 
hairpins in the conventional mirtrons and both 5’ and 3’ tailed hairpins undergo 
debranching by Ldbr and the 3’-tailed mirtrons are trimmed by the RNA exosome 
(Figure 2.1) (Ladewig et al., 2012; Rorbach, Unold, & Konopka, 2018; Westholm & Lai, 
2011). The importance of the splice sites is well-studied in a research group that 
demonstrated artificial mirtrons have much higher knockdown efficiency than shRNAs in 
targeting Myotonic Dystrophy Protein Kinase (DMPK). Additionally, they illustrated that 
their knockdown efficiency is strongly related to their splice sites precision while Drosha 
dependent miRNAs are less efficient in knocking down their targets because Drosha and 
Dicer show fewer accuracy compared to spliceosome activity. This brings an advantage 
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for mirtrons by having less off-targets (Seow et al., 2012; J. O. Westholm, E. Ladewig, 
K. Okamura, N. Robine, & E. C. Lai, 2012).  
Recently, 478 human loci have been identified as diced small RNA duplexes 
derived from splicing which 242 of them are novel. Interestingly, most of the annotated 
introns (86% of the whole mirtrons population) are 5’-tailed and 3’-tailed mirtrons only 
have 3.6% of the totals. This represents the 5’-tailed mirtrons as, by far, the dominant 
class of mirtrons in humans (J. Wen, E. Ladewig, S. Shenker, J. Mohammed, & E. C. Lai, 
2015). Comparing expression of human canonical miRNAs (deep conserved or newly 
evolved) to mirtrons inferred from small RNA sequencing data meta-analysis reveals that 
mirtrons have on average several fold lower abundance (Griffiths-Jones, Grocock, van 
Dongen, Bateman, & Enright, 2006). Furthermore, the distribution of mirtrons is 
bimodal, showing that many species accumulate at the lowest levels of expression 
observed for miRNAs (Figure 2.2). The type of mirtron in the lowest abundance 
population are tailed varieties, consistent with the requirement for additional processing 
during tail removal.  
 
1.6 Regulation of Mirtrons Function by Uridylation 
Several terminal modifications have been identified in pre- and mature miRNAs. 
There are many reports about the effects of nucleotide addition on miRNA biogenesis, 
functionality and stability (J. O. Westholm et al., 2012). Untemplated addition of adenine 
and uridine is the most common modification in miRNAs at their 3’ end especially in 
miRNAs which end in “guanine”. 5’-tailed and 3p-arms of conventional mirtrons 
demonstrate more accumulations of this untemplated addition (J. Wen et al., 2015; J. O. 
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Westholm et al., 2012) and this addition is performed by a class of noncanonical Poly (A) 
Polymerases (PAP) which later was discovered to be a Terminal Uridyltransferase 
(Tailor) (Figure 1.2). Mirtrons demonstrate a bios over uridines and adenines additions to 
the 3’-end. However, other nucleotides may be added but in a very lower rate (J. O. 
Westholm et al., 2012). According to the organism and the examined miRNA, 3’ 
untemplated nucleotide addition shows various impacts on biogenesis and functionality 







Figure 1.2: TUTase. Mirtrons are uridylated due to their 3’ terminal Guanyl 






Uridylation mostly inhibits the biogenesis of mirtrons Altogether, 3’ nucleotide 
addition has vital regulatory role in gene expression (Yashiro & Tomita, 2018). But if this 
pathway suppresses their biogenesis, what is its utility? The answer could be found by 
considering evolutionary context. Tailor prefers splicing derived miRNAs, and this 
makes mirtrons more accessible for uridylation than canonical miRNAs particularly since 
the 3’ terminal “AG” which is mirtron’s 3’ splice site nucleotides is Tailor sequence 
preference as well. This preference is regardless of being lower or higher expressed, well 
conserved or newly evolved. Therefore, it is possible that the mirtrons uridylation 
suppresses their biogenesis to make them less predisposed to deletions or mutations 
excluding them from the evolution. This can make extra evolutionary obstacles for 
mirtrons incorporation into conserved networks (Bortolamiol-Becet et al., 2015; 
Mohammed, Flynt, Siepel, & Lai, 2013; J. O. Westholm et al., 2012).  
 
1.7 Hypothesis  
In previous studies, it was inferred that tail processing of mir-1017, which is a 3’-
tailed mirtron, occurs through exonuclease activity. Although we don’t overlook the 
probable role of exoribonucleases in this process, we wanted to determine if any other 
mechanisms such as endoribonuclease activities are involved in 5’-tailed mirtrons 
biogenesis. Since it has been reported that exoribonucleases and specifically exosome is 
trimming the 3’- tailed mirtrons (3’ to 5’ processing), it is inferred that there might be an 
endoribonuclease activity involved in the process from 5’ to 3’ (Flynt et al., 2010; 
Westholm & Lai, 2011). Furthermore, in several studies, it has been demonstrated that 
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endoribonucleases play key roles in biogenesis or repair systems in tRNA processing on 
their 5’ end and it appears that RNase P is the most important contributor in maturation of 
tRNAs by its endonuclease activity (Cho et al., 2019; Dutta, Malhotra, & Deutscher, 
2012; Spath, Canino, & Marchfelder, 2007; Takaku, Minagawa, Takagi, & Nashimoto, 
2003; Willkomm & Hartmann, 2007; Yip, Savickas, Gygi, & Shao, 2020). Among 
several well-known endoribonucleases, RNase P has been one of the most well-studied 
complexes and its contribution in 5’ to 3’ RNA processing at the junction between the 5’ 
end of double-stranded and single- stranded region of RNA is proved frequently in 
different studies (Altman, 2011; N. Jarrous, 2002; Willkomm & Hartmann, 2007). 
Consequently, all these led us to hypothesize that an endoribonuclease is in charge of 5’-
tailed mirtrons processing and it appears reasonable to focus the efforts on RNase P.  
 
1.8 Significance 
There are a few obscurities in the 5’-tailed mirtron processing mechanism that 
requires illumination. One of the most important questions that we are trying to answer in 
this study is to understand the mechanism by which 5’-tailed mirtrons are processed. 
Specifically, it is important to identify the enzymes that are involved in their maturation. 
Since mirtrons bypass Drosha cleavage, clarifying whether 5’-tailed mirtrons undergo 
individual events and enzymatic reactions to process their tails appears to be an important 
step towards unravelling details about their biogenesis. This unsolved issue demonstrates 
the significance of the study specifically because there are no published studies reporting 
the responsible factor(s) involved in 5’-tailed mirtrons maturation. This is while these 
mirtrons are the most abundant mirtrons. Moreover, knocking down or replacement of the 
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pathogenic alleles by RNAi are attracting more attentions in therapeutic interventions 
recently. Mirtrons are reported to be promising as alternatives to siRNAs, shRNAs and 
artificial miRNAs in this field. Therefore, exploitation and development of their unique 
properties will advantage future studies and therapeutic applications (Seow et al., 2012). 
 
1.9 Objective 
Mirtron 5010 comes from introns of Vacuolar -ATPase (V-ATPase) domains 
which are multi-subunit enzymes that mediate acidification in eukaryotes for zymogen 
activation, protein sorting and other intracellular processes (Gorelick, Shugrue, 
Kolodecik, & Thrower, 2006; Holliday, 2017). mir-5010 located on chromosome 17 is 
annotated on the basis of ~ 2200 small RNA reads present in miRbase.org database. miR-
5010 regulates many genes that have key roles in cell cycles (Flynt et al., 2010). Also, 
miR-668 a 3’-tailed mirtron located on chromosome 12 of mouse genome was selected as 
a control.  
To perform the experiments to achieve our goal, we designed changes in the tail 
regions of the two mirtrons (one 5’- and one 3’-tailed) and then transfected the HEK cells 
with the constructs. Repetitive G-rich sequences are most-likely forming “G quartets” 
which cause the concluded hairpins become more stable than other structures without 
poly G tract (Lerner & Sale, 2019). Therefore, our first objective would be uncovering 
the mechanism (endoribonuclease or exoribonuclease) involved in processing the 5’-
tailed mirtrons. Afterwards, determining which exact ribonuclease(s) is(are) processing 
the 5’ tails in mirtrons will be our next objective. For this purpose, we will knockdown 
selected ribonucleases that have this potential using sequencing. The last step will be 
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confirming our hypothesis through RNA sequencing data analysis along with enzyme 










CHAPTER II – DETECTION OF TAILED MIRTRONS BY NORTHERN BLOTTING      
2.1 Abstract 
microRNAs (miRNAs) have vital roles in regulating gene expression–
contributing to major diseases like cancer and heart disease. Over the last decade 
thousands of miRNAs have been discovered through high throughput sequencing-based 
annotation. Different classes have been described, as well as a great dynamic range of 
expression levels. While sequencing approaches provide insight into biogenesis and 
allow confident identification, there is a need for additional methods for validation and 
characterization. Northern blotting was one of the first techniques used for studying 
miRNAs and remains one of the most valuable as it avoids enzymatic manipulation of 
miRNA transcripts. Blotting can also provide insight into biogenesis by revealing RNA 
processing intermediates. Compared to sequencing, however, northern blotting is a 
relatively insensitive technology. This creates a challenge for detecting low expressed 
miRNAs, particularly those produced by inefficient, non-canonical pathways. In this 
chapter, we describe a strategy to study such miRNAs by northern blotting that involves 
ectopic expression of both miRNAs and miRNA-binding Ago proteins. Through use of 
epitope tags, this strategy also provides a convenient method for verification of small 
RNA competency to be loaded into regulatory complexes.  
Keywords  
miRNA; mirtron; tailed-mirtron; low-abundance detection; RNA-





2.2 Introduction  
Small non-coding RNAs are common features of eukaryotic transcriptomes that 
require specialized detection methods due to their small size. Moreover, many species are 
present in low abundance, which further complicates detection (Q. Huang, Mao, Li, Hu, 
& Zhu, 2014). microRNAs are an ~23 nucleotide (nt) class of small RNAs that have vital 
roles in gene regulation and their dysregulation is associated with numerous diseases 
(Fendereski et al., 2017; Westholm & Lai, 2011). Animal microRNAs are a highly 
diverse class of genes. Some miRNAs are ancient, predating the birth of metazoans, 
while other are newly evolved and species specific (Meunier et al., 2013). Accordingly, 
microRNAs are a highly diversified class of transcript. High throughput sequencing has 
been instrumental in small RNA discovery. Indeed, thousands of miRNAs have been 
discovered and deposited into databases (Berezikov, 2011; Witten, Tibshirani, Gu, Fire, 
& Lui, 2010; J. Zhou et al., 2015). Yet, compared to the number of miRNAs annotated, 
there have been very few functional studies, suggesting there is a need for additional 
strategies for detection.  
miRNA biogenesis typically involves cleavage from hairpin RNAs precursors 
(premiRNAs). For most miRNAs the Drosha/DGCR8-containing microprocessor 
complex excises pre- miRNA from primary transcripts. Final processing is then carried-
out by Dicer, yielding miRNA/miRNA* duplexes (Ketting et al., 2001; Y. Lee et al., 
2003). One strand then is loaded into Argonuate (Ago) proteins where it participates in 
targeting and repression of transcripts (J. E. Babiarz, Ruby, Wang, Bartel, & Blelloch, 
2008; Song, Smith, Hannon, & Joshua-Tor, 2004). Beyond this canonical pathway, there 
are many atypical pathways. Multiple varieties of miRNAs have been found to bypass 
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Drosha/Dgcr8 processing like mirtrons, shRNAs, snoRNA-derived miRNAs, tRNA-
derived miRNAs, and rRNA-derived miRNAs (Figure 2.1) (J. E. Babiarz et al., 2008; 
Ender et al., 2008; Maute et al., 2013; Ruby et al., 2007; Yoshikawa & Fujii, 2016) 
In this article, we will focus on the detection of mirtrons. They are derived from 
small introns that after splicing and debranching can fold into small hairpins (Curtis, 
Sibley, & Wood, 2012; Macfarlane & Murphy, 2010; Westholm & Lai, 2011). Hundreds 
of mirtrons have been discovered in the human genome through inspecting hairpins 
coincident with splice sites from which small RNA sequencing reads are derived 
(Ladewig et al., 2012). Mirtrons are classified in three categories: conventional, 3’-tailed, 
and 5’-tailed. In conventional, both hairpin ends correspond to splice sites and after 
splicing can become dicer substrates. In “tailed” varieties only one side of the hairpin is 
 
 
Figure 2.1: Classes of miRNA defined by biosynthesis pathway. rRNAs, tRNAs and 




at a splice site, while the other side has a stretch of nt’s, or tail, between the hairpin base 
and splice site (J. Wen et al., 2015; Westholm & Lai, 2011). Studies in Drosophila have 
also found that mirtrons are commonly modified by Tailor, a TUTase (terminal 
Uridyltransferase), which uridylates hairpins to inhibit their biogenesis by abrogating 
Dicer processing (Norbury, 2013). Thus, mirtrons more so than other types of miRNAs 
are less robustly expressed than canonical miRNAs.  
Comparing expression of human canonical miRNAs (deep conserved or newly 
evolved) to mirtrons inferred from small RNA sequencing data meta-analysis reveals that 
mirtrons have on average several fold lower abundance (Figure 2.2) (Griffiths-Jones et 
al., 2006). Furthermore, the distribution of mirtrons is bimodal, showing that many 
species accumulate at the lowest levels of expression observed for miRNAs (Figure 2.2). 
The type of mirtron in the lowest abundance population are tailed varieties, consistent 
 
 
Figure 2.2: RDI Plot. 
Showing the distribution of normalized (Reads per million) miRNA expression 




with the requirement for additional processing during tail removal. Therefore, detection 
strategies capable of detecting tailed-mirtrons via northern blotting will be applicable for 
studying all types of low abundance miRNAs. Northern blotting was the first technique 
used to detect a miRNA transcript (R. C. Lee et al., 1993). Many techniques have been 
developed in the interim which frequently rely on reverse transcription and PCR, which 
can introduce bias, artifacts, and mostly can’t distinguish between biogenesis 
intermediates (Sharbati-Tehrani, Kutz-Lohroff, Bergbauer, Scholven, & Einspanier, 
2008; Varkonyi-Gasic, Wu, Wood, Walton, & Hellens, 2007). The challenge in using 
northern blotting is relatively low sensitivity, making detection of tailed-mirtrons 
problematic. Despite this difficulty, it is possible to detect tailed-mirtrons using ectopic 
expression of the miRNA and Ago proteins (Ladewig et al., 2012). In this chapter, we 
describe a protocol for applying this technique to study mammalian tailed-mirtrons. This 
process involves transfection of two constructs, one to express the mirtron and the other 
to express a myc-tagged human Ago2 (Figure 2.3 a). In this system, the mirtron is cloned 
into the open-reading frame of GFP, producing a fluorescent reporter for verification that 
splicing has occurred efficiently. This strategy also takes advantage of a cell culture 
phenomena where increased rates of miRNA biogenesis are observed in cells grown to 
high confluency (Hwang, Wentzel, & Mendell, 2009). Thus, it is critical to use a cell line 
that does not exhibit contact- inhibition. The protocol described here uses Hela cells. 
Following transfection RNAs can either be bulk isolated by a routine RNA purification 
method like TriZol extraction or through immunoprecipitation targeting the myc epitope 
fused to Ago2. Northern blotting, as previously described, involving urea-PAGE 
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separation and transfer to nylon membranes can then be used to visualize RNAs in 




2.3.1 Plasmid Constructs  
Mirtrons are amplified and inserted into expression vectors within opening 
reading frame of GFP [29]. The protocol also utilizes a myc-tagged hAgo2 (Addgene: 
Plasmid #19872). Plasmid DNAs are isolated via commonly-used commercial 






Figure 2.3: System for detecting and verifying mammalian mirtrons. 
a) Constructs for co-transfection. Top vector configured to couple mirtron splicing to GFP 
expression, by interrupting the GFP ORF with the mirtron-containing intron. Bottom vector 
for ectopic expression of Ago2-myc b) Northern Blotting reveals expression of miR-5010, a 





2.3.2 RNA Immunoprecipitation  
Phosphate buffered Saline, lysis buffer (5% Glycerol, 150mM sodium chloride, 
2mM Magnesium Acetate, 20mM, Tris 7.5 pH, 0.5% NP-40, 2mM DTT, 40 units/mL 
RNase Out ® Invitrogen, and Complete mini Protease Inhibitor Cocktail ® Roche). Lysis 
buffer should be used within several days of mixing and kept at 4°C.  
Protein G Dynabeads ® Invitrogen, magnetic stand, and tween-20.  
Anti-myc (clone 9E10, Thermofisher) and a control IgG (Jackson 
Immunoresearch) antibodies. 
Bead preparation and RNA isolation: TRIzol ® Invitrogen, or 400 mM sodium 
chloride, acid phenol chloroform (Ambion), glycogen co-precipitant, isopropanol, 70% 
ethanol, and sodium acetate pH 5.3.  
Hela cells are maintained in DMEM (Dulbecco’s Modified Eagle’s Medium) 
supplemented with 10% FBS and 1% penicillin/Streptomycin using standard cell culture 
methodology. Hela cells are efficiently transfected with Lipofectamine 3000 (Invitrogen) 
to deliver mirtron and myc-Ago2 encoding plasmids, as described above. Transfection 
and splicing efficiency is determined by visualizing GFP fluorescence.  
a. Grow cells to 100% confluency, and change media 3 hours before transfection 
with antibiotics free media. 
b. Warm OptiMEM to room temperature. Make a mixture of OptiMEM, Plasmids, 
and Lipofectamine 3000 based on the scale of transfection in accordance with 
manufacturer recommendations. For this protocol six well plates are typically 
used.  
c. Incubate the mixture at room temperature for 20–25 minutes. 
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d. Add the transfection mixture to the cells dropwise, without touching the plate 
wall. 3.1.5) Swirl the dish gently and incubate for 2 days (37°C, 5% CO2). 
e. Check transfection efficiency two days after transfection.  
 
2.3.3 RNA Isolation 
Following the two-day incubation RNA is harvested. This could be done using the 
TRIzol method, following manufacturer protocols, or immunoprecipitation to isolate 
Ago-miRNA complexes.  
a) TRIzol extraction (optional)  
b) Add TRIzol directly to tissue culture plates. Cells should immediately become 
opaque, and easily dislodged by micropipetting. Remove cells and place in 
microcentrifuge tube. 
c) Incubate TRIzol and cells for 10 mins at room temperature.  
d) Add 200 μl of chloroform to every 1 mL of TRIzol and incubate at room 
temperature for 5 mins. 
e) Separate phases at 4°C for 15 mins by spinning at 13,000 rpm.  
f) Transfer the clear aqueous phase to an equal volume of isopropanol and 
incubate overnight at −20°C. 
g) Spin precipitations at 4°C for 30 mins, resuspend pellets in RNase free water, 
and measure concentration via spectrophotometry. 
h) Immunoprecipitation of miRNA-Ago Complexes (optional).  
i) Wash transfected cells with ice-cold PBS twice while in culture dish. Add 
lysis buffer to cells and incubate 20 mins on ice. Cell layer should begin to 
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detach from the bottom of the dish with gentle micro pipetting. Transfer to 
microcentrifuge tube, mix well with pipette to eliminate clumps, and spin 
down at 13000 rpm for 20 minutes at 4°C to clarify lysate. Transfer 
supernatant to new tube.  
j) Prepare beads for incubation with lysate. Add protein G magnetic beads to 
tubes (two tubes for each sample). Place the tubes on a magnetic stand and 
remove the supernatant. Wash tubes twice with PBS containing 0.02% tween-
20. In PBS-tween add Anti-myc or control IgG antibodies.  
k) Remove PBS tween from beads and add cell lysate from step 3.2.1.1. Reserve 
10% of the volume to be used as input control. Place on rocker for 2 h, 4°C. 
l) Wash beads with lysis buffer five times using magnetic stand to remove beads 
from solution.  
m) Add equal volumes of 400mM NaCl and acid phenol chloroform to beads. 
Aggressively vortex. This procedure should also be performed on the reserved 
10% volume of lysate set aside for input control.  
n) Separate phases at 4°C for 15 mins by spinning at 13,000 rpm. 
o) Add clear aqueous phase to an equal volume of isopropanol and incubate 
overnight at −20°C.  
p) The following day spin precipitations at 4°C for 30 mins, resuspend pellets in 






2.3.4 Northern Blotting 
a) Sample Preparation. If immunoprecipitation was performed samples are ready to 
load on the gel. If TRIzol extraction was used, 20μg of RNA should be loaded in 
each lane.  
b) Reprecipitate 20μg of RNAs by adding the appropriate volume of RNA to 100% 
ethanol containing 300 mM sodium acetate. 
c) Incubate the RNA at −20°C for at least one hour. 
d) Spin precipitations at 4°C for 30 mins, resuspend pellets in RNA II loading 
buffer. 
e) RNAs dissolved in RNA II loading buffer are denatured by incubating at 94°C for 
3 minutes and then immediately placed on ice.  
f) Prepare and Run Gel using a vertical gel rig and the UreaGel system. 3.3.2.1) Mix 
UreaGel diluent, buffer, and concentrate, then add APS and TEMED.  
g) Quickly, using a large volume pipette pour gel mixture between glass plates, 
insert comb, and lay horizontally until gel is set. 
h) Place gel on apparatus and fill buffer tanks with TBE. Pre-run the gel at 250 V for 
30 minutes.  
i) Using long gel loading tips transfer RNA dissolved in RNA II loading buffer to 
the wells of the gel. Prior to loading samples, wells should be washed out to 
remove urea that has diffused into the space. Radio-labeled decade marker should 
also be loaded on the gel.  
j) Run the gel at 250–350 V until the fastest moving, bromophenol blue dye band 
has migrated approximately eight inches.  
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k) Blotting of RNAs onto nylon membranes. 
l) Soak filter paper in 0.5X TBE buffer and place onto wet-dry transfer rig.  
m) Crack the gel using a separator wedge, and cut the region of the gel to be blotted. 
The lower dye band corresponds to ~10 nt RNAs. The gel should be cut 
approximately one inch below the lower band in order to capture all the RNA 
molecules.  
n) Place the gel onto the 0.5X TBE soaked filter paper. 
o) Prepare the membrane by quickly rinsing in water, followed by briefly soaking in 
0.5 X TBE. Once the membrane sinks in the buffer it is ready to be placed on top 
of the gel.  
p) Place another presoaked piece of filter paper on top of the membrane.  
q) Place the lid on the rig. The filter paper/gel/membrane should be sandwiched 
tightly between the electrodes. 
r) Transfer the RNAs to the membrane for 30 mins at 10V at 4°C. 
s) Remove membrane from transfer apparatus, and air dry briefly on a paper towel. 
t) Crosslink the RNAs to the membrane with UV exposure.  
u) Bake the blot at 80°C for 30 mins 3.3.4) Probing and visualizing membranes. 
v) Blots are place into cylindrical hybridization tubes along with enough 
hybridization buffer to keep the blot wet.  
w) Prehybridize blots for >1 hour at 40–45°C, in a rotating hybridization oven. 
x) Prepare radio-labeled probes by mixing water, complementary DNA oligo, 10X 
PNK buffer, PNK, and gamma-P32ATP 6000uCi/mL. 
y) Incubate the labeling reaction at 37°C for > 1hour.  
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z) Stop the reaction by adding EDTA.  
aa) Remove unincorporated radionucleotides using G-25 sephadex columns. Remove 
buffer from column by spinning at 2000rpm for 4 min. Transfer the probe-
labeling reaction to the column and spin again for 2000rpm, 4 min. The probe is 
in the column flowthrough. 
bb) Add the radiolabeled probe to the hybridization solution. Avoid touching the 
membrane with concentrated probe. 
cc) Incubate the membrane overnight at 40–45°C in a rotating hybridization oven.   
dd) Wash and expose the blot. 
ee) Wash the membrane twice with high stringency wash buffer at the hybridization 
temperature for one hour.  
ff) Wash the membrane twice with low stringency wash buffer at the hybridization 
temperature for one hour.  
gg) Remove membranes from tubes, and dab on filter paper. Do not over-dry the 
membrane. The objective is to remove excess liquid. 
hh) Wrap the membrane with cling wrap and expose to X-ray film or to 
phosphorimager screens.  
ii) Develop films or scan screens after one day. 
 
2.3.5 Reprobing Membrane 
a) Signal can be stripped from blots by boiling membranes in 0.1% SDS. Blots 
should be placed in boiling solution and left to cool for three hours. This 
should be repeated once. 
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b) Following the stripping procedure, blots are placed into hybridization buffer 
and the procedure repeated starting at step w.  
c) Blots can be subject to multiple reprobings before the integrity of the 
immobilized RNA is compromised. 
 
2.4 Notes  
A) The protocol described here relies on a radiolabel to visualize the interaction 
of probes with RNAs immobilized on blots. There are alternatives to this type of 
detection, which are untried with mirtrons [30]. These procedures involve an epitope 
labeled probe such as biotin followed by antibody detection leading to visualization 
through chemiluminescence. For labs that want to avoid isotope this could be a viable 
alternative.  
B) This protocol calls for DNA oligonucleotide probes, but is also appropriate for 
use with LNA-based probes. These molecules offer greater specificity compare to DNA 
probes. To use this alternative chemistry the hybridization buffer should be substituted 
with a formulation containing formamide.  
C) LNA hybridization buffer: 50% Formamide, 5X SSPE, 5x Denhardt’s, 0.5% 
SDS, 20ug/ml ssDNA.  
D) Avoid touch nylon membranes with gloves, and then only on the edges. This 
will avoid the appearance of blotting artifacts that might obscure signal.  
E) Care should be taken to load the optimal amount of RNA ladder. The Decade 
Marker protocol calls for a single μl of gamma-P32ATP 6000uCi/ml, but this could lead 
to innapropriatly intense bands that obscure signal if not properly diluted. When fresh 
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ATP is used, the marker should be serially diluted in RNA II loading buffer. 1 μl of 
reaction should be diluted in 30 μl followed by a second dilution in of 1 μl in 30 μl. One 
μl of the final dilution should be loaded on the gel.  
F) Following the final wash step it is typical to observe very little signal 
emanating from the blot via Geiger counter. However, when signals are very weak longer 
exposure times may be required. Experimenters could extend exposure times to a week 
for the lowest signals.  
G) When removing combs from UreaGels the wells should be washed 
aggressively with water to prevent residual acrylamide from polymerizing and causing 
unevenness in the bottom of the well which will result in RNA migration artifacts.  
H) Moderation of voltage used during PAGE separation of RNAs is 





CHAPTER III – HUMAN 5’-TAILED MIRTRONS ARE OROCESSED BY RNaseP  
3.1 Abstract 
Approximately a thousand microRNAs (miRNAs) are documented from human 
cells. A third appear to transit non-canonical pathways that typically bypass processing 
by Drosha, the dedicated nuclear miRNA producing enzyme. The largest class of non-
canonical miRNAs are mirtrons which eschew Drosha to mature through spliceosome 
activity. While mirtrons are found in several configurations, the vast majority of human 
mirtron species are 5’-tailed. For these mirtrons, a 3’ splice site defines the 3’ end of their 
hairpin precursor while a “tail” of variable length separates the 5’ base of the hairpin 
from the nearest splice site. How this tail is removed is not understood. Here we examine 
sequence motifs in 5’-tailed mirtrons and interactions with RNA turnover processes to 
characterize biogenesis processes. Through studying the high confidence 5’-tailed 
mirtron, hsa-miR-5010, we identify RNaseP as necessary and sufficient for “severing” 
the 5’ tail of this mirtron. Further, depletion of RNaseP activity globally decreased 5’-
tailed mirtron expression implicating this endoribonuclease in biogenesis of the entire 
class. Moreover, as 5’-tailed mirtron biogenesis appears to be connected to tRNA 
processing we found a strong correlation between accumulation of tRNA fragments 
(tRFs) and 5’-tailed mirtron abundance. This suggests that dysregulation of tRNA 
processing seem in cancers also impact expression of the ~400 5’-tailed mirtrons encoded 







microRNAs (miRNAs) are small non-coding ~22 nucleotide (nt) RNAs processed 
from stem-loop structures (Bartel, 2018). Biogenesis is initiated by the microprocessor 
which contains Drosha, an RNase III enzyme, that crops ~70 nt precursor hairpin from 
primary transcripts and leaves 2-nucleotide 3’ overhang. The overhangs are recognized 
by Exportin-5 (XPO5), which carries pre-miRNAs to the cytoplasm for final processing 
by Dicer, another RNase III, after which they are loaded into effector Argonaute (Ago) 
proteins. Once recruited by Ago, miRNAs typically base pair with mRNAs via their 5’ 
nucleotides between position 2-9, inducing degradation or translational 
repression(Grimson et al., 2007).  
While most miRNAs mature through the standard Drosha-Dicer-Ago pathway, 
numerous additional routes have been identified that take advantage of alternate RNA 
processing enzymes (Keita Miyoshi, Tomohiro Miyoshi, & Haruhiko Siomi, 2010). 
Indeed, miRNAs have been found to reside in most major non-coding RNA (ncRNA) 
varieties such as tRNAs, rRNAs, and snoRNAs. Each of these ncRNAs are cut from 
longer transcripts, cuts which are repurposed for creation of non-canonical miRNAs. 
Among these the most prevalent variety is tRFs, which are found in numerous cell types 
as a sign of stress and are diagnostic of an oncogenic phenotype (Guzzi & Bellodi, 2020; 
Y. Zhang, Qian, He, & Gao, 2020). This makes many tRNAs dual functional molecules 
with both tRNA and miRNA capabilities such as tRNA-Ile which can form a 110 bp 




Unsurprisingly, the most prevalent RNA processing event in eukaryotes, splicing, 
also generates miRNAs outside the canonical pathway (Okamura et al., 2007; Ruby et al., 
2007; Sibley et al., 2012). miRNAs where the hairpin base is defined by splicesome-
mediated cuts are called mirtrons and were the first recognized class of non-canonical 
miRNA. The initial set of mirtrons were minute introns where the precursor fold 
comprised the length of the entire intron. After splicing, lariat intermediates are linearized 
by Lariat Debranchase (Ldbr) permitting folding into structures that are suitable for 
export, Dicer cleavage, and Ago loading. After this discovery, investigation of 
microprocessor deficient ES cells showed additional types of mirtrons existed where only 
one side of the hairpin corresponded to a splice site (Joshua E. Babiarz et al., 2011). On 
the hairpin terminus that was not a splice site a “tail” of nucleotides extended to the 
scissile base of a distant splice site. Studies in Drosophila revealed that removal of a 3’ 
tail is carried out by the 5’-3’ RNA exosome, which was previously found to be 
confounded by terminal hairpins on substrates (Flynt et al., 2010). Critically, this 
established a paradigm that generic turnover enzymes can participate in productive 
miRNA biogenesis.  
In addition to the alternate method of biogenesis, mirtrons also show a different 
conservation profile relative to miRNAs. Approximately 80 animal miRNAs are 
conserved in all metazoans while mirtrons, as well as other non-canonical miRNAs, are 
rarely found shared at the order taxonomic level (Ladewig et al., 2012; Jiayu Wen, Erik 
Ladewig, Sol Shenker, Jaaved Mohammed, & Eric C. Lai, 2015). Moreover, mirtron 
biogenesis modes are not consistently represented. Three types of mirtrons are observed: 
the original strict mirtrons where splicing generates both ends of the hairpins, 3’-tailed 
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mirtrons where a 5’ splice site coincides with the hairpin base and a tail of nucleotides 
extends to a distal 3’ splice site, and the 5’-tailed mirtrons where the hairpin base is a 3’ 
splice site with a tail between the hairpin and a 5’ splice site. Strict mirtrons are found 
throughout animal genomes with only a handful of examples. Likewise, 3’-tailed 
mirtrons are rare genomic features, which nevertheless are found in invertebrate and 
vertebrates at approximately the same rate. Unlike the other mirtron configurations, 5’-
tailed mirtrons are extremely abundant in mammalian genomes, while essentially absent 
or present at the same rate as 3’-tailed mirtrons in lower organisms. Approximately 450 
human loci have been identified as sources of diced small RNA duplexes derived from 
splicing, remarkably 86% are 5’-tailed mirtrons (Ladewig et al., 2012; Jiayu Wen et al., 
2015).  
Other features further separate mirtrons from standard miRNAs. Comparing 
expression of human canonical miRNAs to mirtrons shows mirtrons have on average 
several fold lower abundances (Ladewig et al., 2012; Jiayu Wen et al., 2015; Zia & Flynt, 
2018). This is potentially linked to a higher rate of terminal modifications identified on 
pre- and mature miRNAs that occur on mirtrons (De Almeida, Scheer, Zuber, & 
Gagliardi, 2018; Le Pen et al., 2018; J. O. Westholm et al., 2012). Mirtrons are highly 
modified by untemplated addition of adenine and uridine carried out by noncanonical 
Poly (A) Polymerases (PAP) or Terminal Uridyltransferase (TUTases) (Bortolamiol-
Becet et al., 2015; Jakub O. Westholm, Erik Ladewig, Katsutomo Okamura, Nicolas 
Robine, & Eric C. Lai, 2012). Nucleotide addition seems to lead to variety of impacts on 
miRNA biogenesis and functionality; however, effects mostly appear to be inhibitory 
(Bortolamiol-Becet et al., 2015; Gutierrez-Vazquez et al., 2017; Heo et al., 2008). 
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Modification can make hairpins poor substrates for Dicer or shift the Dicer cleavage site 
on the pre-miRNA by altering thermodynamic features and thereby modulating strand 
selection by Ago (B. Kim et al., 2015; H. Kim et al., 2020; Yang et al., 2019). Strict and 
5’-tailed mirtrons appear to be more prone to uridylation due to the 3’ terminal “AG” of 
consensus splice sites which is Tailor’s, a terminal uridylyl transferase, preferred 
substrate. This bias suggests that uridylation of mirtrons is used to specifically suppress 
their biogenesis. Thus, not only is there selective pressure working to limit mirtron 
function, but also a targeted modification is applied that further reduces functionality.  
Here, we investigate these seemingly contradictory miRNA species through 
probing biogenesis mechanism of tailed mirtrons in humans. Despite their seeming 
disfavored biogenesis, mirtrons remain abundant (Ladewig et al., 2012; Jiayu Wen et al., 
2015). We show that 3’-tailed mirtrons in mammals likely follows what was found in 
Drosophila. 5’-tailed mirtrons, on the other hand, are produced by the activity of an 
endoribonuclease, which we identified to be RNaseP. This is the enzyme that is 
responsible for removal of 5’ leader segments from tRNA precursors, a structure that 
mirrors the base of 5’-tailed mirtron hairpins (Nayef Jarrous & Reiner, 2007). We also 
find that dysregulation and accumulation of tRFs seen in cancer correlates with a similar 
accumulation of 5’ tailed mirtrons. This further intertwines processing of 5’-tailed 
mirtrons with tRNA processing and suggests that the importance of mirtrons might not lie 






3.3 Results  
3.3.1 5’-Tailed Mirtrons Are Characterized by G-quartet Containing Precursors 
To investigate biogenesis of 5’ tailed mirtrons we first sought to identify shared 
motifs in these miRNAs. To do this, we applied the seqlogo algorithm to the first 20 
bases of small RNAs produced from human 5’-tailed mirtron hairpins (Fig 3.1A-B) 
(Crooks, Hon, Chandonia, & Brenner, 2004). Comparing all species, similar motifs are 
apparent. 5’ arms are comprised primarily of “G” residues while 3’ arms are typically C 
and U residues, likely representing intronic polypyrimidine (ppy) tracts. This situation 
was likewise noted in prior efforts to assess sequence elements in mammalian mirtrons 
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Last 20 Bases 
A 
B 
Figure 3.1:5’-Tailed Mirtrons Elements. A) Mirtrons Have High “G” content on 5p arms and 




elements might be sufficient to lead to 5’-tail mirtron formation. Also, the higher 
confidence G quartet at the beginning of the 5’ arm suggests a major role for hairpin 
structure in biogenesis of 5’-tailed mirtrons. To confirm this, we assessed the prevalence 
of G quartets in all human introns relative to 5’ tail mirtron encoding introns, showing 
significantly higher G quartet occurrence in mirtrons (Fig 3.2). Thus, biogenesis of 5’-
tailed mirtrons appears linked to RNA structure, specifically polyG tracts. To further 
connect 5’-tailed mirtron biogenesis to nucleotide content we compared the free energy 
(G) and GC content of 767 canonical miRNAs 
and 404 5’-tailed mirtrons (Fig 3.3). As a class, 
5’-tailed mirtrons show much high GC content 
relative to most miRNAs. Interestingly, this does 
not seem to correlate with a substantially 
different energy profile. If mirtron hairpin 
energy is greatly divergent from conserved 
miRNAs this might lead to incompatibilities in 
Ago loading.  Considering the bias of 5’ tailed 
mirtrons for G quartets and high GC content this 
suggested that part of their biogenesis might be 
linked to being challenging substrates for 
RNases. To examine this possibility, we 
investigated the impact of major 5’-3’ turnover RNases, Xrn1 and Xrn2, in 5’-tailed 
mirtron production (Valen et al., 2011). 
Figure 3.2: G-Quartets in All Introns and 5’-
Tailed Mirtrons. 5’-tailed mirtrons have 
significantly more G quartets compared to 
all introns. (*p≤0.05). 
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Using public data from XRN 1/2 depleted cells, 5’-tailed mirtrons are expressed 
at a significantly higher level compared to control (Fig 3.4 A-B). A higher level of 
mirtron expression was observed as well as species that were completely absent in 
control conditions appeared after XRN1 1/2 knockdown. Initial reporting of these 
datasets revealed a similar situation, however, this study benefits from a formalized 
annotation of 5’-tailed mirtrons (Jiayu Wen et al., 2015).  
These data suggest that exoribonuclease activity antagonizes mirtron production, 
which led us to investigate the characteristics of mirtrons that only accumulate in Xrn1/2 
knockdown datasets. A notable feature of XRN-eliminated mirtrons is the presence of 
heterogeneous isoforms, where over half were represented by two or more isoforms (Fig 
3.5).  
 
Figure 3.3: Hairpin Energy vs GC Content. Comparison of ∆G (X axis) and GC (Y axis) 
contents in 767 canonical miRNAs and 404 5’-tailed mirtrons. Density overlays show 




This Imprecise processing is consistent with a biogenesis mechanism that is not 
dedicated to mirtron production, unlike the reliability of Drosha to generate precise 
hairpin ends. Focusing on a well-expressed mirtron, hsa-miR-3620, greater heterogeneity 
is seen for 5p arm small RNAs (Fig 3.6). Moreover, the greatest isoform diversity is seen 
at the 5’ end of the 5p read, which is problematic as this shifts the identity of a miRNA’s 
targets. It also hints that 5’-tail removal is not occurring in a deliberate fashion, suggests 
a role for XRN activity in limiting 5’-tailed mirtron accumulation, and that this class of 











































































































































Figure 3.4: XRN 1/2 Degrade 5’-Tailed Mirtrons. A) Normalized accumulation of all combined 
mirtron mapping reads after XRN 1/2 knockdown and in control datasets. B) Number of 







3.3.2 Processing of the ‘-tailed Mirtron, has-miR-5010 
To dissect the biogenesis of 5’ tailed mirtrons we examined hsa-miR-5010 which 
is located in ATP6V0A1 (Fig 3.7). hsa-miR-5010 is one of the most highly expressed 5’-
tailed mirtrons and exhibits relatively consistent 5p arm processing. As a point of 
 
Figure 1. Endoribonucleases are Processing 5’-Tailed Mirtrons. A, B) Mirtrons show high “G”  and 
“CT”  content on 5p and 3p tails, respectively.  C) The number of Poly G on mirtrons structures were 
counted. 5p mirtrons show significantly higher Poly G. D, E) In both miRNAs and mirtrons, ΔG was 
calculated. The blue line shows a decreasing and increasing trend in mirtrons and miRNAs, 
respectively. F) Three constructs were transfected into HEK cells: Wild Type, a 12 x guanine ver-
sion (polyG) and a 20bp inserted version (insert). Mapping of reads to the miR-5010 intron follow-









































































Figure 3.5: Number of isoforms counted for each of the 
mirtrons only found in XRN 1/2 knockdown libraries. 
 
 
Figure 1. E doribonucleases are Processing 5’-Tailed Mirtrons. A, B) Mirtrons show high “G”  and 
“CT”  content on 5p and 3p tails, respectively.  C) The number of Poly G on mirtrons structures were 
counted. 5p mirtrons show significantly higher Poly G. D, E) In both miRNAs and mirtrons, ΔG was 
calculated. The blue line shows a decreasing and increasing trend in mirtrons and miRNAs, 
respectively. F) Three constructs were transfected into HEK cells: Wild Type, a 12 x guanine ver-
sion (polyG) and a 20bp inserted version (insert). Mapping of reads to the miR-5010 intron follow-









































































Figure 3.6: Alignment of Reads at the miR-3620 Locus Found in XRN 1/2 




comparison, we also examined the mouse 3’-tailed mirtron mmu-miR-668, which is 
likewise a high confident tailed mirtron (Fig 3.7) (Ladewig et al., 2012; Seitz et al., 
2004). While there is a homolog of mmu-miR-668 in humans that likewise resides in a 
large miRNA cluster it is only a 3’-tailed mirtron in mice (Seitz et al., 2004). Based on 
the tendency for 5p-tailed mirtrons to harbor polyG tracts we investigated the effect of 
adding polyG tracts into the tails of hsa-miR-5010 and mmu-miR-668. After each mirtron 
was cloned into an expression vector, either a 12G element or a mixed identity 20-
nucleotide insert was placed in the tail of each mirtron (Fig 3.8 A-C). Wildtype, polyG, 
and insert constructs were transfected into HEK 293 cells and expression of the mirtron 
assessed by small RNA sequencing. Consistent with our observations regarding 5’-tailed 
mirtrons, addition of the polyG tract led to greater accumulation of hsa-miR-5010 reads 
while the mixed insert did not (Fig 3.8 A-B). hsa-miR-5010 biogenesis was not perturbed 














ectopically expressed hsa-miR-5010 reads (Fig 3.8B, Fig 3.9). The opposite was seen for 
mmu-miR-668 (Fig3.10 A-B). Both insertions led to decreased expression.  
Increased hsa-miR-5010 expression after polyG insertion was verified using a 
luciferase assay to assess target silencing (Fig 3.8C, 3.12). For the polyG construct we 
observed significant reduction in expression, while very little was seen for WT and insert. 
Together these data suggest that mammalian 5’-tailed and 3’-tailed mirtrons are produced 
by very different mechanisms. The presence of additional nucleotides in mmu-miR-668 
(3’-tailed) resulted in inactivation, which is like what was observed for miR-1017 in 
 Figure 3.8: Endoribonucleases Process miR-5010. A) Accumulation of expression, determined by small 
RNA sequencing, from three mirtron constructs (WT, PolyG and Insert) transfected into HEK 293T. 
Visualization of small RNA read alignments from transfection using the “IGV” software. Left shows the 
modifications made to the different mirtrons. C) Quantification of luciferase activity from a hsa-miR-




drosophila (Flynt et al., 2010). Inhibition of 3’-5’ exoribonucleases by tail inserts 
negatively impacted biogenesis. hsa-miR-5010, in contrast, is enhanced specifically by a 
sequence element inhibitory to exoribonucleases. This is consistent with the effects of 
Xrn1/2 knockdown on 5’-tailed mirtron expression and suggests that this type of mirtron 
is produced by endoribonuclease-mediated severing of tails from hairpins.  
Considering the structure of tailed mirtrons, where a double-stranded RNA is connected 
to an unpaired region, it is reminiscent of immature tRNAs. Excision of tRNAs from 
precursors is carried out by two endoribonucleases: the 5’ Leader cut by RNaseP and the 
3’ Trailer by RNaseZ (Hopper & Nostramo, 2019). In the case of 5’-tailed mirtrons the 
clear fit would be RNaseP. This enzymatic activity is carried out by a multi-subunit 
complex that coordinates the activity of a ribozyme. To assess the role of RNaseP in 
Figure 3.9: Bar Graph Showing Rates of Different Nucleotide Additions. 
Quantification of 3’ modifications from transfected hsa-miR-5010 constructs shows 





mirtron expression, siRNAs targeting the Rpp30 subunit of RNaseP were transfected into 
HEK cells followed by a second transfection with WT hsa-miR-5010 constructs (Fig 3.10 
A-B). After this, small RNA sequencing libraries were created to assess differences in 
expression and processing. The data shows that the expression of hsa-miR-5010 in Rpp30 
knockdown is decreased by half compared to control libraries implicating RNaseP as a 
factor necessary for 5’-tailed mirtron expression (Fig 3.11 A). This led us to evaluate 
differences in RNAs produced from hsa-miR-5010 in control and Rpp30 knockdown 
Figure 3.10: Exoribonucleases Process miR-6668. A) Three mirtron constructs (WT, Poly G and Insert) 
were transfected into HEK 293T cells. In the Poly G, 12 “G”s and in the “Insert” 20 random 
nucleotides were inserted on the 3p tail of mmu-miR-668. Reads from RNA sequencing analysis were 
visualized using “IGV” software. Mirtrons with Poly G tract showed higher mature mirtrons. 
Untemplated “T” nucleotide reads at the 3’ end are observed mostly on 3p end of the 3p arms but less 
than that in 5’-tailed mirtrons. B) Hairpin mapping reads were normalized based on the total number of 





libraries. We detected three different types of endings at the 5’ end of a mature hsa-miR-
5010 (Fig 3.11B). Most of the reads (94%) in control started with “AG” (position 2) and 
when a “U” is added to the 3’ end by uridylation, a 2 nt overhang is obtained which 
resembles a perfect Drosha product. This is while only 4% of the reads start with “CAG”. 
 
A B 
Figure 3.11: miR-5010 Sequencing. A) Quantification of hsa-miR-5010 by high throughput sequencing 
after transfection of control or Rpp30 siRNAs followed by WT hsa-miR-5010 expression construct. B) 
Effects of Rpp30 knockdown on 5’ arm heterogeneity. Dominant position found are listed as 1,2,3 as 



















On the other hand, in Rpp30 knockdown libraries, 5’ processing has been perturbed and a 
shift in the first base is observed and the rate of the “AG” is reduced to 75%. This 
suggests that Rpp30 knockdown has affected the 5’ end processing of hsa-miR-5010. A 
similar analysis was applied to isoforms differing at the 3’ end but there was no 
significant difference detected, further implicating Rpp30 in shaping the 5p arm of 5’-
tailed mirtrons (Fig 3.13).  
To verify the role of RNaseP in processing hsa-miR-5010, we sought to 
reconstitute 5’-tail removal using immunopurified complexes (Fig 3.14 A-B). Antibodies 
against Rpp20, another RNaseP subunit, were used to isolate complexes. In vitro 
synthesized hsa-miR-5010 primary intron transcripts were incubated with these isolated 
Figure 3.13: No change in hairpin 3’ residue identity seen after Rpp30 
knockdown. Single nucleotide addition, which when combined with cleavage at 
the “2” 5’ position yields an ideal Drosha product mimic. 
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complexes or with beads bound to mock anti-rabbit IgG antibodies. Incubation with 
isolates led to significant accumulation of the ~85 nt hairpin of hsa-miR-5010 in the 
RNaseP IP, but not the IgG control. In whole lysate incubation, the RNA is degraded by 
cellular RNases.  Immunoprecipitation efficiency was verified by RT-PCR of the RNA 
subunit of RNaseP, which was greatly enriched in the Rpp20 IP condition relative to 
control IgG (Fig 3.11B). These results indicate that not only is RNaseP necessary for 
processing of hsa-miR-5010, but that it is also sufficient to recapitulate removal of the 







Figure 3.14: RNaseP Immunoprecipitation. A) Incubation of radiolabeled hsa-miR-5010 primary 
intron with immunoprecipitated RNaseP (Rpp20 Ab), mock pull down (cont Ab), or whole cell 
lysate. Processing products were separated on a PAGE-urea gel. B) RT-PCR of RNaseP complex 




3.3.3 5’-Mirtron expression is linked to RNaseP activity 
To assess the effects of Rpp30 loss and its correlation with 5’-tailed mirtrons, we 
compared the expression of all 5’-tailed mirtrons after Rpp30 knockdown to levels found 
in control libraries (Fig 3.15). We find that after knockdown of Rpp30 statistically 
significant changes in 5’-tailed mirtron expression are almost entirely seen in down 
regulated species. This is apart from G values which were not predictive of significant 
down regulation of 5’-tailed mirtrons in Rpp30 knockdown libraries. This reinforces our 
Figure 3.15: RNaseP processing and global 5’-Tailed Mirtron expression. Scatter plot 
showing expression of 5’-tailed mirtrons following Rpp30 knockdown. Blue colored 
data points represent statistically significant changes. Red represents non-significant 




observation that strength of RNA fold does not typically track with expression. The 
exception is the handful of outliers, which do exhibit lower ∆G values. However, outliers 
do not seem to respond consistently to Rpp30 knockdown, suggesting that these changes 
might be more related to host gene expression changes than instructive of changes in 
biogenesis. 
Given the apparent connection of 5’-tailed mirtrons to RNaseP activity we sought 
to correlate changes in mirtron expression with biogenesis of tRFs (Fig 3.16 A-B). In 
small RNA populations, a significant group appear to be derived from pieces of tRNAs 
(Maute et al., 2013). tRFs are not simply degradation products, but are actively loaded 
into Ago proteins (Kuscu et al., 2018; Lyons, Fay, & Ivanov, 2018; Shigematsu & Kirino, 
2015) Production of tRFs occurs through heterogeneous pathway with most segments of 
tRNA clover leaf structures giving rise to small regulatory small RNAs (Yu et al., 2020). 
While the function of tRFs is controversial, their expression has been correlated with an 
oncogenic phenotype (Yu et al., 2020). This suggests that cancer cells have a 
dysregulated tRNA biogenesis, which might also impact 5’-tailed mirtrons. Indeed, after 
surveying public small RNA sequencing from several cancer types we generally observe 
greater expression of 5’-tailed mirtrons relative to control tissues (Fig 3.16A). In all cases 
the mirtrons were either more abundant in cancer or equally distributed between cancer 
and norm. Decrease in cancer was not observed. Intriguingly, the degree to which 5’-
tailed mirtrons are elevated, tracks almost exactly with the abundances of tRFs. The 
exception in this situation is lung cancer where mirtrons were enriched to the same 
degree as tRFs. Even with this outlier, correlation between 5’-tailed mirtrons and tRFs 
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was clear (Fig 3.16B). These results suggest a compelling correlation between changes in 
tRNA processing and 5’-tailed mirtrons, reinforcing a shared biogenesis mechanism.   
 
3.4 Discussion 
In this study, we identified how a large class of human non-canonical miRNAs, 
5’-tailed mirtrons, are processed (Fig 4) (Holzmann et al., 2008; Zia & Flynt, 2018). This 
class of miRNA exhibits distinct features such as high G content on 5’ arms that appears 
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Figure 3.16: tRFs and 5’-Tailed Mirtrons Expressions. A) Expression of 5’-tailed mirtrons and tRFs 
in cancers listed on x-axis. Values are relative difference of RPM values (cancer-norm)/(cancer + 
norm). Letters above plots are significance groups determined by TukeyHSD. B) Plot of Mean 






to be a complement to 3’ splice site adjacent ppy tracts. Prior reports on mirtron features 
report high GC content (J. Wen et al., 2015; J. O. Westholm et al., 2012). Their 
accumulation appears to be highly antagonized by the activity of 5’-3’ exoribonucleases 
such that when this enzymatic activity is genetically depleted expression of 5’-tailed 
mirtrons increases ~4 fold. Moreover, following XRN 1/2 knockdown 5 times as many 
mirtron species become detectable. Linked to inhibition of 5’-3’ processing we also 
observe extreme 5’ arm read heterogeneity. Together these data suggest an antagonistic 
role for 5’ turnover pathways in 5’-tailed mirtron biogenesis. Consistent with this, 
insertion of a 12G tract into a high-confidence human 5’-tailed mirtron, hsa-miR-5010, 
led to a nearly 4-fold increase in mature RNA expression. This is the opposite result to 
what was observed when testing sequence requirements for miR-1017, a 3’-tailed mirtron 
encoded in the Drosophila genome. For miR-1017, exoribonuclease activity of the RNA 
exosome was essential for 3’ tail removal. Interestingly, when we perform a similar test 
with a mammalian 3’-tailed mirtron, mmu-miR-668, a similar result was found. Thus, it 
would seem both vertebrate and invertebrate 3’-tailed mirtrons likely share a biogenesis 
mechanism–exoribonuclease processing. They also suggest for mammalian 5’-tailed 
mirtrons tail removal is likely carried out by an endoribonuclease. Together these results 




In our studies we implicate the activity of RNaseP in the processing of 5’tailed 
mirtrons. This ribozyme containing complex has a role in the maturation of tRNAs by 
removing 5’ leader sequences from precursors. However, studies have found RNaseP to 
interact and cleave a variety of additional transcripts such as pre-rRNA, snoRNAs, along 
with additional nuclear RNAs such as the HRA1 antisense RNA (Chamberlain, Pagan, 
Kindelberger, & Engelke, 1996; Coughlin, Pleiss, Walker, Whitworth, & Engelke, 2008; 
Marvin et al., 2011). Thus, it is not unreasonable to expect this complex to moonlight 
with mitron primary intron transcripts. Moreover, binding affinity of RNaseP is biases to 
Figure 4: 5’-tailed mirtrons can undergo two different processes. They either are processed by 
RNaseP and produce miRNAs or undergo turnover by XRN exoribonuclease activity and will not 
be targeted by RNaseP. 
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nucleotide homopolymers, with greatest preference for polyG, a defining characteristic of 
5’-tailed mirtrons. This with the tRNA-like single-stranded to double-stranded structure 
of 5’-tailed mirtrons further reinforces confidence of RNaseP as the likely 5’-tail 
“severing” enzyme. 
One unclear aspect of 5’-tailed biology is their hyper abundance in mammalian 
genomes. RNaseP is a universal enzyme that is found in all cells and would be able to 
participate in 5’-tailed mirtron biogenesis. Likewise, as 5’-tailed mirtrons appear to arise 
from accumulation of polyG tracts adjacent to the universal eukaryotic ppy tract splicing 
element they should arise at the same rate across many kingdoms (Jacob et al., 2018). 
What then leads to the radical accumulation in mammalian genomes? The answer is 
likely related to the extreme intron length seen in mammals, and the more elaborate 
alternative splicing patterns (Bell, Cowper, Lefranc, Bell, & Screaton, 1998; Hube & 
Francastel, 2015; Roy, Kim, Xing, & Lee, 2008). We propose two possible scenarios. 
First, as do the massive length of mammalian introns, exact placement of strong splicing 
elements such as the ppy are highly favored. A polyG tract could then form through 
neutral evolutionary process to the point that a viable pre-mirtron hairpin arises, which 
then become subject to negative selection. Unfortunately, there is significant constraint 
on the ppy tract such that 5’-tail mirtron 3p arms are unable to acquire hairpin disrupting 
mutations. Harboring the 5’-tailed mirtron is preferable to degrading the strength of the 
ppy track. In the second scenario, the 5’ arm polyG sequence has a role in modulating 
splicing as a cis-element. Here by forming a hairpin that occludes the ppy tract, it might 
lead to alternative 3’ splice choice, and thereby contributing to the greater splicing 
complexity favored by mammalian gene expression programs. The G-quartets could also 
 
52 
be cis-elements that influence alternative splicing through recruitment of hnRNPF (H. 
Huang, Zhang, Harvey, Hu, & Cheng, 2017). In this second scenario 5’-tailed mirtron 
expression is an unintended outcome of a different, favorable arrangement.  
Considering this case, perhaps 5’-tailed mirtrons can be written off as little more 
than genomic detritus. They may shape genomes through disfavoring polyG tracts in 
splice adjacent ppy elements, and thereby apply constraints on ppy neighborhoods. 
However, it might not be a role in normal cell physiology that should draw the attention 
of 5’-tailed mirtron function. As potential regulatory molecules that are diverted from 
Ago loaded by multiple mechanisms such as XRN activity and inhibitory nucleotide 
addition, these mechanisms could become corrupted to serve the subversive genetics of 
cancer cells. Indeed, we find a trend towards increased 5’-tailed mirtron expression in 
cancer-derived small RNA datasets. A similar, and possibly mechanistically related, 
situation is seen with tRFs, which are also amplified in cancer cells. Further, components 
of RNaseP are upregulated in nearly all cancer types (Uhlén et al., 2015; Uhlen et al., 
2017). Both types of non-canonical miRNAs are RNaseP substrates with unclear roles in 
regulation of gene expression. They are excellent candidates for exploitation by cancer 
biology to induce survival promoting gene expression changes as well as excreted RNAs 








3.5 Materials and Methods 
3.5.1 Cell Culture, cloning and transfection. 
Human embryonic kidney (HEK-293T, ATCC) cells were grown in Dulbecco’s 
modified Eagle’s medium (DEMEM, GIBCO) supplemented with 10% Fetal Bovine 
Serum (FBS) and 1% Penicilline-Streptomycine (GIBCO). Cell cultures were maintained 
at 370 C in 5% CO2, 95 % air humidified atmosphere. The constructs to over express the 
mirtrons: mmu-miR-668 and hsa-miR-5010; were cloned in the pcDNA 3.1 vector. All 
the clones were transfected into the HEK-293T cells at 90% confluency using FuGene 6 
as transfection reagent according to the manufacturer’s instructions (Promega). dsiRNAs 
targeting Rpp30 (10 nM) were transfected into HEK 293 cells using Lipofectamine 3000 
reagent according to the manufacturer’s instructions (Invitrogen). Target are available 
on www.idtdna.com. Two days after transfection, the total RNA was extracted and used 
for qRT-PCR or RNA sequencing (Sup Table 1). 
 
3.5.2 Luciferase Assay 
To evaluate functionality of mirtrons constructs a dual reporter luciferase assay 
was used. Briefly, the hsa-miR-5010 hairpin was cloned downstream of Renilla into the 
psiCHECK2 vector (Table 1) Then the plasmid constructs (150 ng) were transfected into 
HEK 293T cells at their 90% confluency using Dual-Luciferase Reporter Assay System 
(Promega). The Luciferase activity was measured 72 h (48h for DsiRNA and 24 h for 
plasmid constructs) according to manufacturer’s instructions. Four replicates were used 




3.5.3 RNA Isolation, qRT-PCR, Sequencing and Analysis pipeline. 
Total RNA was collected from the transfected HEK cells by Trizol extraction 
protocol (Invitrogen,Carlsbad, CA) and 2 μg of each sample was used to make small 
RNA libraries for sequencing. cDNAs was prepared using RevertAid First Strand cDNA 
Synthesis Kit (Thermoscientific) according to the manufacturer’s recommendation to 
perform qRT-PCR (BioRad) (Sup Table 1). Sequencing was performed on the Illumina 
NextSeq platform, and adaptor were clipped using fastx_clipper (Hannon, 2010). Bowtie 
was used for alignments to hg19 or mm10 (Langmead, Trapnell, Pop, & Salzberg, 2009). 
Next, samtools and bedtools were used to quantify reads and examine alignments (H. Li 
et al., 2009; Quinlan & Hall, 2010). The EdgeR R package was used to assess 5’-tailed 
mirtron expression in libraries (Robinson, McCarthy, & Smyth, 2010).  
 
3.5.4 In Vitro Transcription 
Synthetic full length hsa-miR-5010 intron RNA was generated by in vitro 
transcription with MEGAscript® T7 Kit (Invitrogen) using full length intron PCR 
amplification with a T7 encoding forward primer (Sup Table 1). RNAs were radiolabeled 
by addition of alpha-P32 UTP to the reaction. 
 
3.5.5 Immunoprecipitation and In Vitro Enzymatic Processing. 
For immunoprecipitation, the HEK 293T cells were lysed in 0.1% NP-40, 800 nM 
NaCl, 20 mM Tris at 8.0, 30 mM HEPES, 2 mM Magnesium Acetate, Protease Inhibitor 
by sonicated. The insoluble fraction was removed by centrifugation at 14,400 rpm for 15 
minutes at 40 C. After that the supernatant was incubated for 2 hour with 10 uL of Rpp20 
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Antibody (Novus Biologicals) immobilized Dynabeads™ Protein G Immunoprecipitation 
Kit (Invitrogen). The beads were washed five times with IP buffer (0.1% NP-40, 20 mM 
Tris at 8.0, 30 mM HEPES, 2 mM Magnesium Acetate, 150 mM Potassium Acetate), 
using a magnetic stand. The enzyme assay reaction was performed at 370 C for 15 
minutes with incubation buffer (5% PEG, 10 mM MgCl2, 50 mM Tris-HCl, 100 nM 
NH4Cl) by incubating RNAs with RNaseP-bound or control IgG-beads. Beads were 
pelleted and the supernatant was loaded on 8% urea-acrylamide gel and the gel was 
exposed to phosphor imaging plate (Fujifilm) and was read by Typhoon FLA 7,000. In a 
separate run, beads were subject to organic extraction followed by RT-PCR of RNaseP 
RNA subunit.  
 
3.5.6 Cancer Small RNA-Metanalysis. 
Public data from NCBI was used to analyze 5’-tailed mirtron and tRF expression 
(Table 2). Cancer-norm pairs were from same studies. Alignment and read counting was 
performed as described above. tRFs coordinates were obtained for hg19 
http://gtrnadb.ucsc.edu. Counts were normalized to million of reads mapping (RPM) in 








Table 1: Primers and DsiRNAs Used. 
Construct Sequence 
RPP30 F tcagcatggcggtgtttgcag 
RPP30 R gcggctgtctccacaagtccg 
B-Actin F catgtacgttgctatccaggc 
B-Actin R ctccttaatgtcacgcacgat 
hsa-miR-5010 T7 F taatacgactcactataggTGAGTACCTCTCTCCGGGC 
hsa-miR-5010 R ctggggaatgggagacacaaaatcc 
mmu-miR-668 F gtaagtgtgcctcgggtgag 
mmu-miR-688 R cattcacacggagcccactc 








dsiRNA used hs.Ri.Rpp30.13.1 
dsiRNA used CD.Ri.195363.13.5  
Rpph1F ccactgatgagcttccctcc  
Rpph1F ggaggagagtagtctgaattgg  
 
 
Table 2: Public Data Used From NCBI. 




















CHAPTER IV – CONCLUSION AND FUTURE DIRECTION 
Since the discovery of the mirtrons this is the first study working on the 
biogenesis of 5’-tailed mirtrons and 5’ tail removal. We answered the most important 
question about their biogenesis demonstrating that 5’-tailed mirtrons are processed 
through “Endoribonuclease” activity. We then identified the “RNaseP” complex as the 
main enzyme complex involved in this process which is a remarkably influential 
discovery in the field of mirtrons biogenesis specifically in that 86% of the mirtrons are 
5’-tailed mirtrons. Additionally, we uncovered that XRN 1/2 family enzymes contribute 
in the 5’-tailed mirtrons turn over. We also showed the relationship between the changes 
in the mirtrons biogenesis and different human cancers which emphasizes on the 
importance of their biogenesis and modifications on their structures especially 
“Uridylation” on the 3p end.  By altering the involved biogenesis factors, not only the 5’-
tailed mirtron biogenesis is perturbed, but also their arm bios is subjected to shift from 
one arm to another.  This has been reported in cancer studies as well (L. Chen et al., 
2018; Z. Zhang et al., 2019). Therefore, studying the relationship between uridylation on 
3p end of mirtrons and their biogenesis with different cancers to elucidate the molecular 
mechanism in this process can be an outstanding future topic. 
Moreover, it is unclear exactly how many of other subclasses of ncRNAs are 
expressed in all aspects of living organisms and especially higher mammalians. 
Therefore, we postulate that there might be more examples of alternative non-canonical 
pathways resulting in small RNAs. Hence, revealing more details of how and to what 
extent the genes are regulated through unexplored non-canonical RNAs, appears to be an 
enigmatic prospect of this field. This could be applied to other Drosha independent 
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pathways such as shRNAs in which they generate miRNAs. This can be a leading 
indication to investigate whether RNaseP complex is processing shRNAs in the same 
fashion as mirtrons are. 
To date, about 500 mirtrons have been annotated in the human genome, covering 
almost 20% of the total canonical miRNA population. Besides, remarkable elaborations 
have been disclosed in understanding their biogenesis details. However, still some 
uncertainties regarding mirtron’s turnover, export pathways and modifications requires 
future explorations. Additionally, experiments are needed to identify targets of these non-
canonical miRNAs to address their biological function and significance. This can be a 
boon for researchers in the field to uncover the relevance of mirtrons to diseases. This has 
become more challenging in mirtrons biogenesis and functionality after we revealed that 
there is a strong correlation with changes in 5’-tailed mirtron processing with tRNA, 
proposing shared biogenesis mechanism. In addition, by revealing more structural 
features of mirtrons such as high G content, the path to define more reliable 
computational algorithms of discovering novel mirtrons seems more feasible. By this, 
few mirtrons that might have been incorrectly annotated as mirtrons can be removed from 
the list. Moreover, defining algorithms that help recognizing the cleavage site of the 
RNaseP complex on mirtrons seems an area in which much effort could be invested.  
There has been attempts to introduce artificial mirtrons as therapeutic implements; 
however, more evidence and considerations seem indispensable. This becomes more 
crucial now that pharmaceutical companies and research laboratories are racing to 
pioneer RNAi-based drugs to treat diseases like cancers and Alzheimer’s. This has 
become more challenging during the COVID-19 pandemic and global accessibility and 
 
59 
application of RNA-based vaccines which signifies increasing demands on the emergence 
of new technologies and discoveries in RNA-based drugs as a prominent approach to 
overcome ever-challenging and even future diseases. Our findings here in this study, 
regarding mirtron G content and polyG tract blocking the maturation process from 5’ end 
might be applicable in designing better siRNAs. About half of the mirtrons with lower 
∆G were downregulated in RNaseP knockdown. Therefore, better siRNAs can be 
designed by considering ∆G level of the designs. On the other hand, more considerations 
on the 5’ end of the siRNAs seems reasonable to avoid being degraded by ribonucleases 
such as XRN 1/2 before they are delivered in the cell to target the gene of interest. 
On the other hand, another area which seems essential to provide more evidence 
is to assess as to why mirtrons have emerged since they are reported to be poorly 
conserved and most of them are not retained during the evolution. Perhaps the answer 
could be found in the natural selection as their primary sequence has evolved quickly. 
This infers that while much has been done on mirtrons in recent years, there is still many 
studies to be accomplished in their evolutionary investigations.  
Overall, our findings on RNaseP and XRN family provides influential small RNA 
functional applications in future studies revealing biogenesis pathways of other known 
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